Related Experiment Videos
[Pharmacological possibilities in treatment hypoacusis in children]
A Pruszewicz1, A Obrebowski, B Woźnica
1Kliniki Foniatrii i Audiologii AM, Poznaniu.
Insights
This study compared hearing rehabilitation in children with sensorineural hypoacusis and sudden hearing loss. Cerebrolysin showed a 36% improvement in the first group, while standard therapy yielded 30% improvement in the second.
Area of Science:
- Audiology
- Neuroscience
- Pediatrics
Background:
- Hypoacusis, or hearing loss, presents diverse etiological factors and requires tailored rehabilitation strategies.
- Understanding the dynamics of hearing thresholds and speech progress is crucial for effective treatment.
- Children with sensorineural hypoacusis and sudden hearing loss represent distinct patient populations requiring different therapeutic approaches.
Purpose of the Study:
- To analyze hearing threshold dynamics and rehabilitation progress in children with hypoacusis.
- To compare the efficacy of different treatments based on the etiological factor of hearing loss.
- To evaluate the impact of Cerebrolysin versus standard therapy on hearing and speech rehabilitation.
Main Methods:
- Two groups of children with hypoacusis were studied: one with deep sensorineural hypoacusis and a central component, the other with sudden hearing loss.
- The first group received Cerebrolysin, a central nervous system stimulant.
- The second group underwent standard sudden deafness therapy (mannitol, hydrocortisone, vitamins, enzymes). Objective hearing examinations were conducted before and after treatment for both groups.
Main Results:
- A 36% improvement in examination results was observed in the group treated with Cerebrolysin.
- The group receiving standard therapy for sudden deafness showed a 30% improvement in hearing after treatment.
- Both treatment protocols demonstrated some efficacy in improving hearing outcomes for the respective pediatric populations.
Conclusions:
- Cerebrolysin may offer a beneficial therapeutic option for children with deep sensorineural hypoacusis and a central component.
- Standard therapy for sudden deafness also shows positive results, indicating the importance of timely and appropriate intervention.
- Further research is warranted to elucidate the long-term effects and optimal use of these treatments in pediatric hypoacusis.
Abstract:
The purpose of this work was to present the dynamics of hearing thresholds and the progress in rehabilitation of hearing and speech according to the treatment applied and probable etiological factor of hypoacusis. Two groups of children were examined. The first group consisted of children with deep sensorineural hypoacusis together with central component of hypoacusis, whereas the second group included children with sudden occurrence of hypoacusis or detorioration of diminished hearing ability. The first group received a treatment with a drug stimulating the function of central nervous system, Cerebrolysin (Minden, D), whereas the other one underwent typical therapy applied in case of sudden deafness (mannitol, hydrocortison, vitamins, enzymes). Both the groups were subjected to objective examination of hearing before and after the treatment. The improvement in examination results in the first group was observed in 36%. In patients suffering from sudden deafness the improvement in hearing after treatment was found respectively in 30%.